Latest filing published 27 Nov 2023 for 华海药业.
陈保华: trading record in brief
陈保华 is a declared insider of 华海药业 (board member), with filings sourced from SSE / SZSE (CSRC). Over a trading history stretching from 21 November 2023 to 27 November 2023, the count stands at 3 filings.
The open-market record is one-sided, with 3 purchases worth €2.5M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
In size, the median ticket on the buying side is €640k. No cluster: in 3 purchases, no other insider of the company bought within 30 days.
On 27 November 2023 came the latest disclosure, an open-market purchase for €640k in 华海药业. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Companies and markets linked to 陈保华
Open company profiles for insider transactions, fundamentals and analyst consensus when available.